| abstract |
(57) Abstract Disclosed are N-heterocyclic compounds that interfere with cytokine production by inhibition of p38 kinase. As a specific example, the compounds of the present invention have the formula I: Indicated by Also disclosed are methods of manufacture, pharmaceutical compositions and methods of treating conditions involving inappropriate p38 kinase activity or TNF-α expression using the compounds of the invention. |